Oncology Data Solutions for HEOR & Research
Ontada is uniquely positioned to provide the up-to-date, granular and robust data required to reach more-informative evidence and research insights faster. Our research-ready clinical data is available for immediate analysis, overcoming the cumbersome hurdles associated with harmonizing claims data or chart reviews.
Our research oncology data solutions, ON.OutcomesView and ON.JourneyView, integrate the quality real-world data (RWD) and state-of-the-art analysis needed for evidence generation. Ontada’s comprehensive clinical data also allows researchers to follow granular trends over the entire patient journey, creating powerful evidence for stakeholders, reimbursement and opportunity identification.
Empowering oncology breakthroughs with RWD and insights
Ontada’s research-ready data provides a rich, detailed view of patient demographics, diagnosis, testing, treatment choices and outcomes. ON.OutcomesView allows researchers to examine disease progression patterns, treatment failures and molecular markers to pinpoint areas where improvements are needed and inform evidence-based strategies. Clients can also monitor near real-time adaptations to changing standards of care and understand treatment performance to expedite analyses, publications and stakeholder engagement discussions.
ON.JourneyView is uniquely positioned to efficiently analyze patient-level EHR data to reveal patient journey insights. In doing so, researchers can produce a detailed view of patient care to identify critical treatment junctures and potential means to improve patient-centered care. ON.JourneyView leverages AI- and ML-enhanced common data models to generate actionable insights, speed evidence generation and adjust research based on the latest clinical evidence.
Leverage Ontada’s up-to-date, clinical RWD to generate better evidence faster
Transparent results
Understand, explain, defend, and trust results by leveraging AI- and ML-enhanced common data models to enable complete, traceable, and interoperable insights, accelerating speed to evidence
Rapid insights
Quickly adjust your research to the latest clinical evidence, reflecting near real-time adaptation to changing standards of care
Representative data
Benefit from the depth and breadth of our clinical record data to deliver tailored solutions that address the unique needs of oncology
Point-of-care technology
Monitor point-of-care decisions for robust evidence generation
Population-based evidence
Inform evidence-based strategies by leveraging diverse outcomes data in specific patient populations
Patient-care insights
Examine patterns in disease progression, treatment failures, and molecular markers to pinpoint areas where new interventions or improvements are needed
Supporting research across the product lifecycle
- Understand and follow patients from early-stage diagnosis through entire treatment journey
- Rapidly conduct RWD research to identify endpoints reflective of up-to-date clinical practice patterns, including biomarker testing, utilization rates, recurrence-free survival, and overall survival
- Determine the most effective treatment protocols and where further research or education may be needed
- Identify all patients diagnosed with a specific cancer in The US Oncology Network
- Utilize detailed patient-level data for precise analysis, ensuring diverse patient populations are represented
- Uncover the rationale behind clinical decisions for a complete understanding of testing and treatment patterns
- Gather evidence that can expand indications to move line of therapy
- Evaluate broader populations to understand areas of unmet need relative to standard of care and generate evidence that support opportunities for expanded utilization of products
- Generate evidence where products will produce improved outcomes across specific patient populations
- Understand and follow patients from early-stage diagnosis through entire treatment journey
- Rapidly conduct RWD research to identify endpoints reflective of up-to-date clinical practice patterns, including biomarker testing, utilization rates, recurrence-free survival, and overall survival
- Determine the most effective treatment protocols and where further research or education may be needed
- Identify all patients diagnosed with a specific cancer in The US Oncology Network
- Utilize detailed patient-level data for precise analysis, ensuring diverse patient populations are represented
- Uncover the rationale behind clinical decisions for a complete understanding of testing and treatment patterns
- Gather evidence that can expand indications to move line of therapy
- Evaluate broader populations to understand areas of unmet need relative to standard of care and generate evidence that support opportunities for expanded utilization of products
- Generate evidence where products will produce improved outcomes across specific patient populations
Evidence generation requires sufficient breadth and depth to provide actionable insights into oncology patient care. Ontada’s research data products can remove clinical data and analysis barriers to furnish researchers with the relevant, up-to-date RWE they require.